Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - Adamas Pharmaceuticals Inc | a2219480zs-1a.htm |
| EX-5.1 - EX-5.1 - Adamas Pharmaceuticals Inc | a2219480zex-5_1.htm |
| EX-10.3 - EX-10.3 - Adamas Pharmaceuticals Inc | a2219480zex-10_3.htm |
| EX-10.6 - EX-10.6 - Adamas Pharmaceuticals Inc | a2219480zex-10_6.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Amendment No. 3 to the Registration Statement on Form S-1 of Adamas Pharmaceuticals, Inc. of our report dated March 5, 2014, except with respect to our opinion on the consolidated financial statements insofar as it relates to the stock split as described in Note 15 as to which the date is March 24, 2014, relating to the consolidated financial statements of Adamas Pharmaceuticals, Inc., which appears in such Registration Statement. We also consent to the reference to us under the heading "Experts" in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
San Jose, California
April 7, 2014